ASP-2215,
ASP2215,
gilteritinib,
Gilteritinib,
1254053-43-4,
ASP2215,
ASP-2215,
UNII-66D92MGC8M,
Gilteritinib (ASP2215),
66D92MGC8M,
6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide,
2-Pyrazinecarboxamide, 6-ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-,
Gilteritinib [USAN:INN],
Xospata,
2-Pyrazinecarboxamide, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-,
ASP 2215,
gilteritinib-asp2215,
Gilteritinib(ASP2215),
Gilteritinib (USAN/INN),
Gilteritinib (ASP-2215),
SCHEMBL282229,
GTPL8708,
CHEMBL3301622,
BDBM144315,
C29H44N8O3,
BCP28756,
3694AH,
MFCD28144685,
s7754,
AKOS030234455,
ZINC113476229,
CS-3885,
DB12141,
SB16988,
KS-0000064E,
NCGC00481652-01,
NCGC00481652-02,
AC-29030,
AS-35199,
HY-12432,
QC-11768,
A14411,
D10709,
US8969336, 547,
US8969336, 577,
6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide,
6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide,
6-Ethyl-3-[3-methoxy-4-[4-(4-methylpiperazine-1-yl)piperidino]anilino]-5-[(tetrahydro-2H-pyran-4-yl)amino]pyrazine-2-carboxamide,